🚀 VC round data is live in beta, check it out!
Carmat Valuation Multiples
Discover revenue and EBITDA valuation multiples for Carmat and similar public comparables like Pheton Holdings, Bioretec, enVVeno Medical, Predict and more.
Carmat Overview
About Carmat
Carmat is a France-based company dedicated to designing, manufacturing, and marketing Aeson, the artificial heart. The company's mission is to establish Aeson as the primary alternative to heart transplantation, offering a life-saving therapeutic option for patients with end-stage biventricular heart failure who face a severe shortage of donor hearts.
Founded
2008
HQ
Employees
153
Website
Financials (FY)
EV
$72M
Carmat Stock Performance
Carmat has current market cap of $7M, and enterprise value of $72M.
Market Cap Evolution
Carmat's stock price is $0.11.
| EV | Market Cap | Price 1D | Price 1M | Price 3M | Price 12M | EPS |
|---|---|---|---|---|---|---|
| $72M | $7M | 0.0% | XXX | XXX | XXX | — |
Benchmark Trading Valuation Multiples by Industry
Sign up to access valuation multiples like growth-adjusted P/E, Rule of 40, next 12-month EV/Revenue, EBITDA multiples by industry, consensus analyst estimates and many more.
Start Free TrialCarmat Valuation Multiples
Carmat Financial Valuation Multiples
As of April 20, 2026, Carmat has market cap of $7M and EV of $72M.
Equity research analysts estimate Carmat's 2025E EV/Revenue multiple at XXX and 2025E EV/EBITDA multiple at XXX
| LTM | NTM | Last FY | FY 2026 | FY 2027 | FY 2028 | |
|---|---|---|---|---|---|---|
| Market cap (current) | $7M | XXX | $7M | XXX | XXX | XXX |
| EV (current) | $72M | XXX | $72M | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc. and Morningstar, Inc.
Verified Carmat Valuation Multiples
Access all public comps and forward-looking valuation multiples like EV/Revenue in 2027, based on consensus analyst estimates. Powered by FactSet and Morningstar.
Carmat Public Comps
See public comps and valuation multiples for other Medical Devices comps.
| EV/Revenue | EV/EBITDA | |||||
|---|---|---|---|---|---|---|
| LTM | 2026E | 2027E | LTM | 2026E | 2027E | |
| Carmat | XXX | XXX | XXX | XXX | XXX | XXX |
| Pheton Holdings | XXX | XXX | XXX | XXX | XXX | XXX |
| Bioretec | XXX | XXX | XXX | XXX | XXX | XXX |
| enVVeno Medical | XXX | XXX | XXX | XXX | XXX | XXX |
| Predict | XXX | XXX | XXX | XXX | XXX | XXX |
| Iconovo | XXX | XXX | XXX | XXX | XXX | XXX |
| XXXXXXXX | XXX | XXX | XXX | XXX | XXX | XXX |
| XXXXXXXX | XXX | XXX | XXX | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc.
Carmat M&A Activity
Carmat acquired XXX companies to date.
Last acquisition by Carmat was on XXXXXXXX, XXXXX. Carmat acquired XXXXXXXX for XXX (EV/Revenue multiple of XXX).
Latest Acquisitions by Carmat
| Acquired Company | Valuation | EV/Revenue | EV/EBITDA |
|---|---|---|---|
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
Get Verified M&A Valuation Multiples
Sign up to see revenue and EBITDA valuation multiples for 150K+ M&A deals.
Start Free TrialCarmat Investment Activity
Carmat invested in XXX companies to date.
Carmat made its latest investment on XXXXXXXX, XXXXX. Carmat invested in XXXXXXXX for XXX (EV/Revenue multiple of XXX).
Latest Investments by Carmat
| Company | Valuation | EV/Revenue | EV/EBITDA |
|---|---|---|---|
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
Benchmark 350K+ Funding Rounds and Disclosed VC Valuation Multiples
Sign up to see data on 350K+ funding rounds and disclosed revenue and EBITDA valuation multiples, from seed, through growth stage, to pre-IPO.
Start Free TrialAbout Carmat
| When was Carmat founded? | Carmat was founded in 2008. |
| Where is Carmat headquartered? | Carmat is headquartered in France. |
| How many employees does Carmat have? | As of today, Carmat has over 153 employees. |
| Is Carmat publicly listed? | Yes, Carmat is a public company listed on Berlin Stock Exchange. |
| What is the stock symbol of Carmat? | Carmat trades under CXT ticker. |
| When did Carmat go public? | Carmat went public in 2010. |
| Who are competitors of Carmat? | Carmat main competitors are Pheton Holdings, Bioretec, enVVeno Medical, Predict. |
| What is the current market cap of Carmat? | Carmat's current market cap is $7M. |
| Is Carmat profitable? | No, Carmat is not profitable. |
Start Your
Free Trial Today
Try Multiples for free for 3 days. Got questions or need a demo? Schedule a call with us below.